A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
(Bloomberg) A two dose course of Pfizer Inc. and BioNTech SE’s Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from South Africa’s Africa Health Research Institute said.
(Bloomberg) Johnson & Johnson’s vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain’s ability to get around one pillar of the body’s defenses.
Johnson & Johnson's vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain's ability to get around one pillar of the body's defenses.
(Bloomberg) Johnson & Johnson’s vaccine produced virtually no antibody protection against the omicron coronavirus variant in a laboratory experiment, underlining the new strain’s ability to get around one pillar of the body’s defenses.